Streamline Health Net Worth
Streamline Health Net Worth Breakdown | STRM |
Streamline Health Net Worth Analysis
Streamline Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Streamline Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Streamline Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Streamline Health's net worth analysis. One common approach is to calculate Streamline Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Streamline Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Streamline Health's net worth. This approach calculates the present value of Streamline Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Streamline Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Streamline Health's net worth. This involves comparing Streamline Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Streamline Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Streamline Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Streamline Health's net worth research are outlined below:
| Streamline Health is way too risky over 90 days horizon | |
| Streamline Health appears to be risky and price may revert if volatility continues | |
| Streamline Health has high likelihood to experience some financial distress in the next 2 years | |
| Streamline Health Solutions currently holds 13.12 M in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Streamline Health has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Streamline Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 17.9 M. Net Loss for the year was (10.16 M) with profit before overhead, payroll, taxes, and interest of 8.88 M. | |
| Streamline Health Solutions currently holds about 5.92 M in cash with (1.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 17.0% of Streamline Health outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates OLO, ENZB, STRM on Behalf of Shareholders |
Streamline Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Streamline Health Solutions. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Streamline Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 24th of April 2024 Upcoming Quarterly Report | View | |
| 31st of January 2024 Next Fiscal Quarter End | View |
Know Streamline Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Streamline Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Streamline Health Solutions backward and forwards among themselves. Streamline Health's institutional investor refers to the entity that pools money to purchase Streamline Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Tower Research Capital Llc | 2025-03-31 | 1.3 K | Cwm, Llc Duplicate | 2025-03-31 | 86.0 | Advisor Group Holdings, Inc. | 2025-03-31 | 66.0 | Bank Of America Corp | 2025-03-31 | 32.0 | Jpmorgan Chase & Co | 2025-03-31 | 5.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Harbert Fund Advisors Inc | 2025-03-31 | 321.6 K | Vanguard Group Inc | 2025-03-31 | 112.6 K | Nicholas Hoffman & Company, Llc | 2025-03-31 | 52.3 K | Geode Capital Management, Llc | 2025-03-31 | 37.2 K | Blackrock Inc | 2025-03-31 | 20.8 K |
Follow Streamline Health's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.04 M.Market Cap |
|
Project Streamline Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.45) | (1.38) | |
| Return On Capital Employed | (0.64) | (0.61) | |
| Return On Assets | (0.29) | (0.30) | |
| Return On Equity | (0.83) | (0.79) |
When accessing Streamline Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Streamline Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Streamline Health's profitability and make more informed investment decisions.
Evaluate Streamline Health's management efficiency
Streamline Health has return on total asset (ROA) of (0.111) % which means that it has lost $0.111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6393) %, meaning that it created substantial loss on money invested by shareholders. Streamline Health's management efficiency ratios could be used to measure how well Streamline Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of July 2025, Return On Tangible Assets is likely to grow to -1.38. In addition to that, Return On Capital Employed is likely to grow to -0.61. At this time, Streamline Health's Non Currrent Assets Other are very stable compared to the past year. As of the 21st of July 2025, Total Current Assets is likely to grow to about 9.1 M, while Non Current Assets Total are likely to drop about 19.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.06 | 4.86 | |
| Tangible Book Value Per Share | (4.06) | (3.86) | |
| Enterprise Value Over EBITDA | (8.92) | (9.36) | |
| Price Book Value Ratio | 1.50 | 1.43 | |
| Enterprise Value Multiple | (8.92) | (9.36) | |
| Price Fair Value | 1.50 | 1.43 | |
| Enterprise Value | 388.7 M | 399.9 M |
The strategic initiatives led by Streamline Health's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 1.9354 | Revenue | Quarterly Revenue Growth (0.01) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Streamline Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Streamline Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Streamline Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Streamline Health Corporate Filings
| 10th of July 2025 Other Reports | ViewVerify | |
8K | 1st of July 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 30th of June 2025 Other Reports | ViewVerify | |
10Q | 16th of June 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Streamline Health Earnings per Share Projection vs Actual
Streamline Health Corporate Management
| Ben Stilwill | President | Profile | |
| Donald Vick | Director Analytics | Profile | |
| Bryant Reeves | Interim Staff | Profile | |
| Lance Seach | Senior Development | Profile | |
| Jawad Shaikh | Chief Officer | Profile | |
| Benjamin Stilwill | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (2.22) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.